There's A Secret SkinCeuticals Sale Happening Right Now
If you're a fan of SkinCeuticals skincare, you're probably aware that the brand rarely ever runs sales. Its products are also usually excluded from beauty retailers' seasonal savings events, making it next to impossible to score a discount. But right now, there's a secret SkinCeuticals sale happening at Dermstore.
Here are all the details on this week's secret SkinCeuticals sale.
Now through the end of the day on June 6, code SKINC15 will get you 15% off most of the brand's products—including the best-selling C E Ferulic serum and Triple Lipid Restore 242 cream. And best of all, there doesn't appear to be a limit on how many products you can use the code on. So whether you're looking to restock your existing SkinCeuticals lineup or try out a couple of new products for less, it's a great time to buy. Here's what our editors recommend adding to your cart while it's 15% off.
Dermstore
Our beauty editors named this formula the best vitamin C serum overall. It's packed with 15% pure L-ascorbic acid (a form of vitamin C), vitamin E and ferulic acid, which work together to fade dark spots and even out your skin tone. Director of features and special projects Kim Peiffer has been using this formula for years. 'With consistent use I notice fewer dark spots, less inflammation and a more youthful appearance overall. I love how well it absorbs into skin, and I notice a stark difference in the brightness of my skin if I stop applying it for a few days in a row,' she says.
Dermstore
After consulting a dermatologist, our beauty team named this cream the best face moisturizer overall. It's deeply hydrating, fast-absorbing and includes 2% ceramides to help your skin retain moisture. I've been using this formula for the past couple of years, and it's exactly what my parched sensitive skin needs. I love that despite being very hydrating, it never feels heavy or greasy on my face.
Dermstore
Speaking of parched skin, if you're looking to lock in moisture, consider adding this serum to your cart. Made with 1.3% hyaluronic acid and a proprietary ingredient called Proxylane, it plumps the skin to reduce the appearance of fine lines while also boosting radiance.
Deputy editor Rose Sala says her facialist recommended this product and she's quickly become a fan. 'I love the way it goes on—a little thicker than other serums—and I notice my drier skin really soaks it up and benefits from it. [It's] nice to combine with the C E Ferulic and Triple Lipid moisturizer for more nourished and glowy skin,' she explains.
Dermstore
SkinCeuticals created this serum to mimic the effects of botox injections. It contains a special peptide blend, plus niacinamide, polyhydroxy acid and laminaria extract. According to the brand, this combo visibly reduces wrinkles and improves skin texture so you don't have to resort to injections. That said, it can also be used to complement neurotoxin injections, targeting hard-to-reach areas of the face.
Dermstore
As someone with sensitive skin, I've been scared to delve into the world of retinols. But I recently picked up this product, which SkinCeuticals recommends for first-time retinol users. Featuring 0.3% retinol, it's gentler than most formulas on the market. The brand recommends using it only once or twice per week and then increasing to at least three times per week as long as your skin tollerates it.
Dermstore
If you're already an avid SkinCeuticals user, you might want to add the RGN-6 Regenerative Cream to your skincare routine. It's the brand's newest product, and it's supposed to mimic the kind of skin regeneration effects you'd get from a laser treatment. With regular use, it's designed to reduce redness, acne marks, dark spots and wrinkles while increasing smoothness and firmness.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
More than half of Utahns favor legalizing recreational marijuana: Poll
A majority of Utahns favor legalizing marijuana for recreational use by adults in the state, according to a new poll. The survey conducted in May for the Deseret News and Hinckley Institute of Politics found 53% — 30% strongly and 23% somewhat — support legalization, while 43% oppose it. In addition, the poll shows 77% support Utah's current medicinal marijuana law, which has been in place since 2018. HarrisX conducted the online poll of 805 registered Utah voters May 16-21. It has a margin of error of plus or minus 3.5 percentage points. Utahns' opinions of recreational marijuana have shifted the past few years. A 2016 poll conducted by Dan Jones & Associates showed only 22% favored legalizing marijuana for recreational use, while 77% opposed making it legal. An April 2023 Deseret News/Hinckley Institute poll found 40% believe marijuana should be legal for both recreational and medical use, while 51% say it should be medical only. The survey also showed nearly 4 in 10 Utahns were concerned medical cannabis could lead to legal recreational use, while about 6 in 10 did not share that concern. There's currently no campaign to legalize marijuana for recreational use, and Utah legislative leaders say they would oppose such an effort. In 2014, the Utah Legislature passed what's known as Charlee's law allowing the use of cannabidiol, or CBD, to treat epileptic seizures. Four years later, voters narrowly approved a ballot initiative extending the use of cannabis for other health conditions amid opposition from the Utah Medical Association, Salt Lake Chamber, Utah Episcopal Diocese, The Church of Jesus Christ of Latter-day Saints and law enforcement. State lawmakers rewrote the law and passed a negotiated bill soon after the public vote. As of May, Utah had 15 medical cannabis pharmacies statewide, including several that make home deliveries. Cumulative sales since the first pharmacy opened in 2020 are approaching $600 million, according to the Utah Department of Health and Humans Services' Center for Medical Cannabis. Just over 101,200 residents have active medical cannabis cards, the vast majority issued to treat persistent pain, with PTSD and cancer a distant second and third, respectively. Utah Senate President Stuart Adams expressed opposition to Utah expanding beyond medicinal use. 'Utah already has a responsible, well-balanced and effective program that ensures individuals with chronic pain or serious illnesses have access while maintaining strong safeguards to prevent misuse. States that have expanded legalization beyond medical use have seen serious social consequences, including increased homelessness and criminal activity. I oppose further expansion because our focus should remain on what truly benefits our state and the well-being of all Utahns,' the Layton Republican said in a statement to the Deseret News. Utah House Speaker Mike Schultz, R-Hooper, also opposes recreational marijuana. 'Our current approach ensures Utahns have access to relief while maintaining important safeguards for public health and safety. I remain firmly opposed to legalizing recreational marijuana. It's encouraging to see that a strong majority of Utahns – 77% – agree that our focus should remain on providing benefit to those who need it most," he said in a statement to the Deseret News. While the Deseret News/Hinckley Institute poll showing a majority of Utahns favor legalized recreational marijuana use might be surprising, it aligns with another recent survey. The results mirror a survey Noble Predictive Insights did for the medical marijuana advocacy group Keep Utah Medical in March. That poll found 52% of Utahns would support a ballot initiative legalizing recreational cannabis in the state, while 38% would not. Alex Iorg, co-founder of the medical cannabis company WholesomeCo as well as co-founder of Keep Utah Medical, commissioned that survey to see where Utahns stood on the recreational issue. 'I guess we're not surprised by those results. That's what we both have found,' he said of the Noble and Deseret News/Hinckley Institute polls. 'But we're seeing this incremental increase of support and I think it's part of this challenge to get medical access. Our hope is that we can improve access to medical cannabis so that we can avoid a recreational ballot initiative." A survey Noble did for the group last October found 50% of Utahns say cannabis should be legal for adults for therapeutic, medical and recreational purposes. Iorg said there's a 'whole herd' of issues that come with recreational marijuana. Medical programs and patients in other states are often 'vilified,' he said, causing people to call for recreational ballot initiatives. In Utah, 'that's a long way off from being successful even at 53%. What we prefer is having a medical program that's supported and focused on medical.' Noble offered this analysis of its poll results: 'YES wins the left and the middle and divides the right. In a red state like Utah, that's enough to get to a solid — though not overwhelming — margin of victory. 'Over the last decade, major political victories came from a populist-traditionalist coalition: The GOP's wings would coalesce, form a majority together, and govern. If legalization were to win, the coalition would be built from left to right — a progressive minority joining with the center and Republican moderates. This is possible — but it requires careful execution.' Currently, 24 states, two U.S. territories and Washington, D.C., legalized marijuana for adult recreational use, according to the National Conference of State Legislatures. Thirty-nine states allow the medical use of cannabis. The Deseret News/Hinckley Institute poll shows much stronger support for legalization among self-identified Democrats and independents than among self-identified Republicans. Nearly three-fourths of Democrats and nearly two-thirds of independents expressed support compared to 43% of Republicans. Broken down by political ideology, 86% of liberals favored legalization, followed by 59% of moderates and 38% of conservatives, according to the poll. Among age groups, 18- to 34-year-olds, showed the highest support at 65%, while those over 65 showed the least at 36%. Support for recreational marijuana legalization exceeds 50% in all four of the Utah congressional districts. It approached 60% in the state's most populous counties, except for Davis and Utah counties at 45% and 43%, respectively. Self-identified members of The Church of Jesus Christ of Latter-day Saints in the poll were decidedly against legalization, with 31% in favor and 66% opposed. Among all self-identified Christians, 43% favor legalization, while 53% oppose it. Men showed stronger support than women, 56% to 50%. Utahns, regardless of political persuasion, overwhelmingly support the state's medical marijuana law — 73% of self-identified Republicans and 80% of self-identified Democrats. Independents came in at 81%, according to the Deseret News/Hinckley Institute poll. The survey also found 69% support for the medical marijuana law among Latter-day Saints and 73% among all Christians. 'It's no longer unacceptable to try cannabis for medical purposes. A lot of people know someone that has benefitted from it directly. There's a lot of exposure to the benefits,' Iorg said. Medical cannabis works and saves lives, he said, adding it's less harmful than prescription opioids. It doesn't solve all the world's problems, he said, but it does help a lot of people, especially those looking for relief. People over 65 showed stronger support for medical marijuana than younger people, but all age groups were above 70%. Support across Utah's congressional districts and most populous counties was also high, the poll shows. Baby boomers are the largest users of cannabis, Iorg said. 'Now, health and wellness is their No. 1 priority and cannabis has shown to be a great tool, especially for pain and sleep.'
Yahoo
2 hours ago
- Yahoo
Here's what to know about the twice-yearly preventative HIV shot
The Food and Drug Administration has approved a twice-yearly preventive HIV shot that could protect millions from the virus. People at risk for HIV may choose to take PrEP, a medication that helps prevent HIV infection. PrEp has been prescribed as a daily pill or a shot given every two months. This new twice-yearly drug called lenacapavir is now the longest-lasting type of PrEP. Ian Haddock, a Houston man who participated in a study of the drug, told The Associated Press it 'expands the opportunity for prevention.' 'Now I forget that I'm on PrEP because I don't have to carry around a pill bottle,' he said. The shot, made by Gilead Sciences, is injected under the skin of the abdomen. It leaves a small 'depot' of medication that slowly absorbs into the body. 'This really has the possibility of ending HIV transmission,' Greg Millett, public policy director at amfAR, The Foundation for AIDS Research, told the AP. But the upheaval in U.S. healthcare — including cuts to public health agencies and Medicaid — and slashing of American foreign aid to fight HIV are clouding the prospects. Millett said "gaping holes in the system" in the U.S. and globally "are going to make it difficult for us to make sure we not only get lenacapavir into people's bodies but make sure they come back' even as little as twice a year. Gilead's drug already is sold to treat HIV under the brand name Sunlenca. The prevention dose will be sold under a different name, Yeztugo. Gilead didn't immediately announce its price. The drug only prevents HIV transmission – it doesn't block other sexually transmitted diseases. Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide. Only about 400,000 Americans already use some form of PrEP, a fraction of those estimated to benefit. A recent study found states with high use of PrEP saw a decrease in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection they can use without a partner's knowledge or consent. One rigorous study in South Africa and Uganda compared more than 5,300 sexually active young women and teen girls given twice-yearly lenacapavir or the daily pills. There were no HIV infections in those receiving the shot while about 2% in the comparison group caught HIV from infected sex partners. A second study found the twice-yearly shot nearly as effective in gay men and gender-nonconforming people in the U.S. and in several other countries hard-hit by HIV. Haddock, who leads the Normal Anomaly Initiative, a nonprofit serving Black LGBTQ+ communities, had tried PrEP off and on since 2015 but he jumped at the chance to participate in the lenacapavir study and continues with the twice-yearly shots as part of the research follow-up. 'Men, women, gay, straight – it really just kinds of expands the opportunity for prevention,' he added. Just remembering a clinic visit every six months 'is a powerful tool versus constantly having to talk about, like, condoms, constantly making sure you're taking your pill every day.' 'Everyone in every country who's at risk of HIV needs access to PrEP,' Dr. Gordon Crofoot of Houston, who helped lead the study in men, told the AP. 'We need to get easier access to PrEP that's highly effective like this is.'
CBS News
2 hours ago
- CBS News
Pandemic-era puppies, kittens now filling San Francisco shelters beyond capacity
The COVID-19 pandemic is still having a deadly effect on the pet population. The number of unwanted animals is straining San Francisco's shelter capacity to the breaking point, sometimes with tragic results. Just about every animal shelter in the state is jammed these days and it all points back to the pandemic when shelters were empty and it was hard to find any animal to adopt, as people tried to cope with COVID isolation. But also at that time, spaying and neutering were suspended or drastically reduced. And now those generations of puppies and kittens are filling the shelters. "So, not just in San Francisco, but in California and nationwide, we are like two million spay/neuters behind. So, that just leads to more and more accidental breeding," said Virginia Donohue, Executive Director of San Francisco's Animal Care and Control. "Pre-pandemic, we were full a couple times a year. Now we're full a couple times a month. It is a constant problem. It's no longer an occasional problem." And it can have heartbreaking consequences. SF Animal Care and Control works to find unwanted pets a home, but when none is available, they must turn to euthanasia to make room. "We try very hard to euthanize just for medical and behavior issues," said Donohue. "But there are points when an animal is here too long and nobody is coming for it, we don't have a place for it to go and its behavior is deteriorating. Then we're going to euthanasia." One of the reasons the city's public animal shelter is so full is because its major adoption partner, the San Francisco SPCA, is taking a lot fewer dogs and cats than it used to. The SF SPCA, which is a private entity, has joined forces with the Stockton SPCA and is now rescuing a lot more unwanted pets from the Central Valley. "Historically, they've taken as many as 600 dogs," said SF's Donohue. "Currently, it's under 200. So, obviously, that's a pain point." It's also a reason why Animal Care and Control is having to turn to euthanasia. Another is that the shelter has a "custody" program that holds dogs up to two weeks for people who go to jail or the hospital or who die. That all takes space from those pets looking to be adopted. On Saturday, a dog owner named Ethan said he sometimes wonders where they're all coming from. "To see the amount of people out there that have dogs that aren't taking care of them, like, I don't really understand how they got these dogs in the first place," he said. The dogs are out there, many in desperate need of a caring home. But there is only so much space in the shelters and reducing the population is now more than just a humane thing to do. It's becoming a matter of life and death. "I mean, don't get a dog if you weren't intending to get a dog," Donohue said. "But if you want a dog, just look at your local shelter first. Even if you don't find the dog of your dreams there, just look and see what's available."
